10.21147/j.issn.1000-9604.2017.06.09
Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy
clinical characteristics、growth factor receptor、treatment outcomes、kinase inhibitors、response rate、lung cancer
29
R73;R5
This study was supported in part by grants from the National Natural Science Foundation of China 81372392 and 81402486
2018-02-06(万方平台首次上网日期,不代表论文的发表时间)
共10页
543-552